Stay updated on Atezolizumab and Epacadostat Combination Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab and Epacadostat Combination Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website’s revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-22T02:35:56.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The NIH transition announcement banner was removed from the top of the page; the 403 error and the rest of the page remain.
    Difference
    1%
    Check dated 2026-11-08T05:26:39.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T02:32:16.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study page. The former 403 error message and its Home link are no longer displayed.
    Difference
    2%
    Check dated 2026-10-25T02:34:07.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.1 to v3.7.2 on the forbidden-access page.
    Difference
    0.2%
    Check dated 2026-10-18T02:20:53.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:22:02.000Z thumbnail image

Stay in the know with updates to Atezolizumab and Epacadostat Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.